Histogenics Corporation to Present at Canaccord Adams Genuity Musculoskeletal Conference

2/3/2012 6:38:03 AM

WALTHAM, Mass.--(BUSINESS WIRE)--Histogenics Corporation, a privately held, regenerative medicine company, today announced that President and Chief Executive Officer Patrick O’Donnell will present at the upcoming Canaccord Genuity Musculoskeletal Conference on February 7th at 3:30pm PT at the Parc 55 Wyndham in San Francisco. Mr. O’Donnell will discuss the Company’s lead product candidates, including NeoCart®, an autologous bioengineered neocartilage grown outside the body using the patient’s own cells for the regeneration of cartilage lesions and VeriCart™, a three-dimensional cartilage matrix to stimulate cartilage repair in a simple, one-step procedure. NeoCart recently entered a Phase 3 clinical trial and will be the subject of an oral presentation at the Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS), which is also taking place in San Francisco from February 7th-11th.

Read at BioSpace.com

Read Article at

Related Companies

News Categories

• BioSpace.com

• Histogenics Corporation

• Canaccord Adams

• Biotech/Pharma - Events

• Medical Devices

• Medical Dev. & Diag. - Events